Head-to-head comparison
Longevixx vs Nova
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Longevixx prices 19 peptide programs publicly but keeps its GLP-1 ladder behind the intake, where the advertised $149 turns out to be the first month only.
From $199/mo sema · From $299/mo tirz · Verified September 2026
Marked down on: The advertised $149 is a first-month rate; the standing price is $199 and only appears inside the intake.
Desk Score
Nova folds the $99 membership into one all-in figure and prices an oral daily option beside the injection, but three different price sets are live on the site at once.
From $198/mo sema · From $210/mo tirz · Verified September 2026
Marked down on: Three price sets are live at once: $198 and $210 on the product pages, against $229 and $279 in those same pages' FAQ answers.
Nova takes this head-to-head with the higher Desk Score, 74/100 (C) against 66/100 (C) for Longevixx. Longevixx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Longevixx
66/100
C
Nova
74/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Longevixx | Nova |
|---|---|---|
| Semaglutide | From $199/moFrom $199/mo (compounded) | From $198/moFrom $198/mo (starting dose, compounded) |
| Tirzepatide | From $299/moFrom $299/mo (compounded) | From $210/moFrom $210/mo (starting dose, compounded) |
| Coverage | All 50 states claimed, no list published | 49 states (not California) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Anyone browsing a broad peptide catalog who will check the second month's price before subscribing. | Anyone who wants the membership inside the price rather than beside it, and an oral option priced openly. |
| Desk Score | 66/100C | 74/100C |
The verdict
Desk pick — NovaNova takes this head-to-head with the higher Desk Score, 74/100 (C) against 66/100 (C) for Longevixx. Longevixx still holds its ground where its strengths line up with yours.
Choose Longevixx if…
Anyone browsing a broad peptide catalog who will check the second month's price before subscribing.
From $199/mo sema · From $299/mo tirz · All 50 states claimed, no list published
Choose Nova if…
Anyone who wants the membership inside the price rather than beside it, and an oral option priced openly.
From $198/mo sema · From $210/mo tirz · 49 states (not California)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Longevixx · Nova.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Longevixx
- CoreAge Rx vs Nova
- Curex vs Longevixx
- Curex vs Nova
- Fitish vs Longevixx
- Fitish vs Nova
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.